NCBS Home page
Accession List
Pathway List
Search
Authorized Users
Help
News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.
Search in: Search for Match By

 
Result: 1 - 5 of 5 rows are displayed

Reaction List for pathway CaM (Pathway Number 27) in Accession fig4_synapse (Accession Number 3)

Entries are grouped according to Pathway Number and they are alternately color coded using  and  color.
Further ordering can be done to the table header.  indicates that ordering is done according to ascending or descending order.
Keq is calculated only for first order reactions.
Kd is calculated only for second order reactions. [nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules]
  Reaction
Name		Pathway Name / 
Pathway No.		KfKbKdtauReagents
1 
  • neurogranin-bind
    -CaM
    		• CaM

    Pathway No. 27    		0.3
    (uM^-1 s^-1)    		1
    (s^-1)    		Kd(bf) = 3.3333(uM)-  Substrate:
     neurogranin
     CaM

     Products:
     neurogranin-CaM
    2 
  • dephosph-neurogr
    anin
    		• CaM

    Pathway No. 27    		0.005
    (s^-1)    		0
    (s^-1)    		--  Substrate:
     neurogranin*

     Products:
     neurogranin
    3 
  • CaM-TR2-Ca2-bind
    -Ca
    		• CaM

    Pathway No. 27    		3.6
    (uM^-1 s^-1)    		10
    (s^-1)    		Kd(bf) = 2.7778(uM)-  Substrate:
     CaM-TR2-Ca2
     Ca

     Products:
     CaM-Ca3
    4 CaM-TR2-bind-CaCaM

    Pathway No. 27    		72
    (uM^-2 s^-1)    		72
    (s^-1)    		Kd(af) = 1(uM)-  Substrate:
     CaM
     Ca
     Ca

     Products:
     CaM-TR2-Ca2
    5 CaM-Ca3-bind-CaCaM

    Pathway No. 27    		0.465
    (uM^-1 s^-1)    		10
    (s^-1)    		Kd(bf) = 21.5054(uM)-  Substrate:
     CaM-Ca3
     Ca

     Products:
     CaM-Ca4
     
    Result: 1 - 5 of 5 rows are displayed


    Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
    This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.